Now, Vyalev (foscarbidopa and foslevodopa) has become the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in advanced Parkinson's ...
Vinir Engineering Ltd has filed preliminary papers with capital markets regulator SEBI seeking its approval to float an initial public offering (IPO). The IPO is entirely an Offer-for-Sale (OFS ...